Literature DB >> 8911137

Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.

X Y Li1, L T D'Orazio, J Y Niederkorn.   

Abstract

The immunological privilege of the anterior chamber (AC) of the eye is due, at least in part, to a selective antigen-specific down-regulation of delayed-type hypersensitivity (DTH) and a normal induction of antibody responses: a phenomenon that has been termed anterior chamber-associated immune deviation (ACAID). This dichotomy in the systemic immune responses is suggestive of a T-helper type-2 (Th2)-dominated immune phenotype in which a Th2 cell population is preferentially activated and cross-regulates T-helper type-1 (Th1) effector elements. This hypothesis was tested by comparing the cytokine pattern of antigen-pulsed spleen cells from mice primed in the anterior chamber with antigens that induce ACAID with responses in hosts primed with antigens that do not induce ACAID. The results indicated that CD4+ spleen cells from hosts primed in the AC with antigens that induce ACAID produced significant quantities of interleukin-10 (IL-10) but insignificant levels of IL-2, IL-4 and interferon-gamma (IFN-gamma). In contrast, hosts primed in the AC with antigens that do not induce ACAID, but instead elicit normal DTH, displayed cytokine patterns indicative of a Th1 response significant quantities of IL-2 and IFN-gamma were produced while IL-4 and IL-10 secretion was insignificantly different from normal controls. The immunological phenotype of the AC-primed hosts could be altered by systemic treatment with antibodies against either a Th1 cytokine (IFN-gamma) or a Th2 cytokine (IL-10). Hosts treated with anti-IL-10 antibody and subsequently primed in the AC with ACAID-inducing antigens developed normal DTH responses, while hosts treated with anti-IFN-gamma antibody and primed in the AC with antigens that normally produce positive DTH responses failed to develop positive DTH collectively the results support the proposition that immune privilege in the AC of the eye is due to the selective activation of a Th2 population that cross-regulates Th1 responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8911137      PMCID: PMC1456675          DOI: 10.1046/j.1365-2567.1996.d01-714.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  HSV-1 retinitis and delayed hypersensitivity in DBA/2 and C57BL/6 mice.

Authors:  D Kielty; S W Cousins; S S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-12       Impact factor: 4.799

3.  Role of splenic B cells in the immune privilege of the anterior chamber of the eye.

Authors:  J Y Niederkorn; E Mayhew
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

4.  Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye.

Authors:  J Y Niederkorn; J W Streilein
Journal:  Transplantation       Date:  1982-06       Impact factor: 4.939

5.  Selective and specific inhibition of 24 hour skin reactions in the guinea-pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy.

Authors:  G L Asherson; S H Stone
Journal:  Immunology       Date:  1965-09       Impact factor: 7.397

6.  Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.

Authors:  T L Knisely; M W Luckenbach; B J Fischer; J Y Niederkorn
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

7.  Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.

Authors:  D L Sacks; P A Scott; R Asofsky; F A Sher
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

8.  Cyclophosphamide-sensitive contrasuppression in TNP-anterior chamber associated immune deviation (TNP-ACAID).

Authors:  J C Waldrep; H J Kaplan
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

9.  Spontaneous immune rejection of intraocular tumors in mice.

Authors:  J Y Niederkorn; P C Meunier
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-06       Impact factor: 4.799

View more
  13 in total

1.  Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man.

Authors:  M Muhaya; V L Calder; H M Towler; G Jolly; M McLauchlan; S Lightman
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 2.  Immune mechanisms in uveitis.

Authors:  R R Caspi
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye.

Authors:  M Takahashi; N Ishimaru; K Yanagi; K Saegusa; N Haneji; H Shiota; Y Hayashi
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 5.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea.

Authors:  Bobbie Ann Austin; William P Halford; Bryan R G Williams; Daniel J J Carr
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

7.  CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye.

Authors:  Molly E Skelsey; Elizabeth Mayhew; Jerry Y Niederkorn
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

8.  Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis.

Authors:  Y Gao; J M Herndon; H Zhang; T S Griffith; T A Ferguson
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

9.  A penetrating ocular injury can affect the induction of anterior chamber-associated immune deviation.

Authors:  Fang Lei; Junfeng Zhang; Jinsong Zhang; Hao He; Ying Du; Peizeng Yang
Journal:  Mol Vis       Date:  2008-02-11       Impact factor: 2.367

10.  Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.

Authors:  Wensheng Li; Fansheng Kong; Xia Li; Xufeng Dai; Xiaoqiang Liu; Qinxiang Zheng; Ronghan Wu; Xiangtian Zhou; Fan Lü; Bo Chang; Qiuhong Li; William W Hauswirth; Jia Qu; Ji-Jing Pang
Journal:  Mol Vis       Date:  2009-02-06       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.